Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment
Sayan Koley, Application Specialist at Imperial Biotek, shared a post on LinkedIn:
”Lupus Anticoagulant: A Key Marker in Thrombosis Risk Assessment
Despite its name, Lupus Anticoagulant (LA) is not an anticoagulant in the body.
It is an autoantibody that interferes with phospholipid-dependent coagulation tests and is strongly associated with an increased risk of thrombosis.
Why is it important? Associated with venous and arterial thrombosis
- Plays a major role in the diagnosis of Antiphospholipid Syndrome
- Linked to recurrent pregnancy complications
- Critical for patient risk assessment and treatment planning
Laboratory Detection
- Screening Tests: dRVVT, LA-sensitive aPTT
- Mixing Studies
- Confirmatory Tests with excess phospholipid
- Persistent positivity after 12 weeks supports
clinical significance
Key Message:
A prolonged clotting time in vitro does not necessarily indicate a bleeding risk.
In many cases, Lupus Anticoagulant is associated with an increased tendency to form blood clots.
Accurate testing, proper interpretation, and close collaboration between clinicians and laboratory professionals are essential for optimal patient care.”
Stay updated with Hemostasis Today.
-
Jul 26, 2026, 01:48Rob Maloney: Why Global Diagnosis is the Missing Piece in Bleeding Disorder Care
-
Jul 26, 2026, 01:35Moustafa Abdou: Ehlers-Danlos Syndrome – Why Collagen Matters for Hemostasis
-
Jul 26, 2026, 01:25Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
-
Jul 26, 2026, 01:06Christine Bork: Why Misinformation Around a Single Vitamin Postpartum is Putting Babies at Risk
-
Jul 26, 2026, 00:44A Significant Step Forward For People With Bleeding Disorders In The Dominican Republic – WFH
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026